• Development of a nose-poke restricted vaporized cocaine self-administration model in mice
  Published on 2026-06-25
  3 months ago
• Transdiagnostic mapping of common and specific regional homogeneity alterations across affective and psychotic disorders
  Published on 2026-06-25
  3 months ago
• Selective orexin receptor cross-over treatment increases resilience and expression of neuroplastic signaling genes
  Published on 2026-06-21
  3 months ago
• Recent advances in individual differences in addiction neuroscience in animal models and clinical studies
  Published on 2026-06-21
  3 months ago
• Acute and post-acute neurobehavioral responses to lysergic acid diethylamide in healthy subjects: a randomized controlled study
  Published on 2026-06-18
  3 months ago
• Serotonin type 3 receptor (5-HT3R) antagonists for negative symptoms and cognitive impairment associated with schizophrenia: a systematic review and meta-analysis
  Published on 2026-06-17
  3 months ago
• Modulation of early non-rapid eye movement slow wave activity by ketamine in treatment-resistant depression
  Published on 2026-06-16
  3 months ago

« Previous 1 … 12 13 14 15 16 … 143 Next »

• Psychological support in psychedelic-assisted therapy clinical trials: A systematic review
  Published on 2026-03-20
  6 months ago
• Roland R. Griffiths, psychopharmacology pioneer: Abuse liability, alcohol, nicotine, caffeine, benzodiazepines, and psychedelics
  Published on 2026-03-20
  6 months ago
• Pharmacological characterization of 4-F-3-Me-α-PVP: A novel synthetic cathinone with psychostimulant effects and abuse liability in rodents
  Published on 2026-03-14
  6 months ago
• A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive–compulsive disorder
  Published on 2026-03-14
  6 months ago
• Enhancement of memory network activity in schizophrenia patients by phosphodiesterase-4 (PDE4) inhibitor, roflumilast: A pilot study
  Published on 2026-03-11
  6 months ago
• The effects of transcranial direct current stimulation (tDCS) on subjective, autonomic and neuropsychological response in the 7.5% CO2 experimental model of anxiety
  Published on 2026-03-11
  6 months ago
• Effects of ayahuasca on neuropsychological performance and social cognition: A systematic review
  Published on 2026-03-09
  6 months ago

« Previous 1 … 12 13 14 15 16 … 154 Next »

• Antipsychotic plasma concentration as predictor of movement disorders and cardiometabolic side-effects: A comparison with prescription dose
  Published on 2026-01-23
  8 months ago
• Esketamine in bipolar depression: Unreproducible data
  Published on 2026-01-23
  8 months ago
• Gene-environment interactions and white matter integrity in mood disorders: Further directions
  Published on 2026-01-18
  8 months ago
• Child and maternal hair oxytocin: A novel biomarker of dyadic emotional availability
  Published on 2026-01-17
  8 months ago
• Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocols
  Published on 2026-01-17
  8 months ago
• Response to the letter regarding “Default mode network integrity across neuropsychiatric disorders and its relation to social dysfunction: A normative modelling approach”
  Published on 2026-01-15
  8 months ago
• Biomarker innovations in precision psychiatry diagnostics and treatment strategies
  Published on 2026-01-15
  8 months ago

« Previous 1 … 12 13 14 15 16 … 170 Next »